Home > Boards > US Listed > Biotechs > ProNAi Therapeutics Inc (SRRA)

Now the other two analysts give SRRA average

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Value_Investor Member Profile
 
Followed By 833
Posts 79,228
Boards Moderated 17
Alias Born 07/26/07
160x600 placeholder
Sierra Oncology Reports Decreased Transfusion Requirements for Patients Treated with Momelotinib Directly Compared to Ruxolit... PR Newswire (Canada) - 12/7/2019 9:00:00 AM
Sierra Oncology Reports Decreased Transfusion Requirements for Patients Treated with Momelotinib Directly Compared to Ruxolit... PR Newswire (US) - 12/7/2019 9:00:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 12/6/2019 7:31:57 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/3/2019 4:40:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/3/2019 4:17:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/3/2019 4:16:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/3/2019 4:15:46 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/2/2019 5:34:26 PM
Sierra Oncology Announces Investor Event to Discuss Momelotinib Data Being Reported at ASH PR Newswire (Canada) - 12/2/2019 7:00:00 AM
Sierra Oncology Announces Investor Event to Discuss Momelotinib Data Being Reported at ASH PR Newswire (US) - 12/2/2019 7:00:00 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 11/27/2019 6:06:06 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 11/26/2019 6:42:28 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/26/2019 7:07:53 AM
Sierra Oncology Announces Closing of $103 Million Public Offering and Changes to its Board of Directors PR Newswire (Canada) - 11/26/2019 7:00:00 AM
Sierra Oncology Announces Closing of $103 Million Public Offering and Changes to its Board of Directors PR Newswire (US) - 11/26/2019 7:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 11/25/2019 5:30:32 PM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 11/25/2019 4:49:00 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 11/25/2019 4:06:16 PM
Sierra Oncology Launches the MOMENTUM Phase 3 Clinical Trial for Patients with Myelofibrosis PR Newswire (Canada) - 11/20/2019 7:00:00 AM
Sierra Oncology Launches the MOMENTUM Phase 3 Clinical Trial for Patients with Myelofibrosis PR Newswire (US) - 11/20/2019 7:00:00 AM
Sierra Oncology to Present at the Jefferies 2019 London Healthcare Conference PR Newswire (Canada) - 11/14/2019 4:05:00 PM
Sierra Oncology to Present at the Jefferies 2019 London Healthcare Conference PR Newswire (US) - 11/14/2019 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/13/2019 4:21:59 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/7/2019 5:24:58 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/7/2019 5:21:03 PM
Value_Investor   Monday, 11/18/19 10:30:05 AM
Re: BuynowCryLater post# 658
Post # of 747 
Now the other two analysts give SRRA average $3.00 target from the link below!

https://www.marketscreener.com/SIERRA-ONCOLOGY-INC-33296232/consensus/

Disagreed: those greedy shorters will be burned down to the ground if they Dare to short at such ridiculous low price levels! The Longs will make huge gain very soon v.s. the Shorters will be buried deeply with huge losses...

I would suggest them to cover ASAP before the Quadtriple Quick rally starts!

Stock-Killers-World has spot 440 stock killers from 9000-Bagger to 2.2-Bagger since 03/05/2011
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist